UTICA, N.Y.--(BUSINESS WIRE)--Feb. 28, 2017--
CONMED Corporation (NASDAQ: CNMD) today announced that its Board
of Directors has declared a quarterly cash dividend of $0.20 per share,
payable on April 5, 2017 to all shareholders of record as of March 15,
2017.
About CONMED Corporation
CONMED is a medical technology company that provides surgical devices
and equipment for minimally invasive procedures. The Company’s products
are used by surgeons and physicians in a variety of specialties,
including orthopedics, general surgery, gynecology, neurosurgery and
gastroenterology. The Company distributes its products worldwide from
several manufacturing locations. CONMED has a direct selling presence in
17 countries, and international sales constitute approximately 50% of
the Company’s total sales. Headquartered in Utica, New York, the Company
employs approximately 3,300 people. For more information, visit www.conmed.com.
Forward-Looking Statements
This press release contains forward-looking statements based on
certain assumptions and contingencies that involve risks and
uncertainties, which could cause actual results, performance, or trends
to differ materially from those expressed in the forward-looking
statements herein or in previous disclosures. For example, in addition
to general industry and economic conditions, factors that could cause
actual results to differ materially from those in the forward-looking
statements may include, but are not limited to, the risk factors
discussed in the Company's Annual Report on Form 10-K for the fiscal
year ended December 31, 2016. Any and all forward-looking
statements are made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995 and relate to the
Company’s performance on a going-forward basis. The Company believes
that all forward-looking statements made by it have a reasonable basis,
but there can be no assurance that management’s expectations, beliefs or
projections as expressed in the forward-looking statements will actually
occur or prove to be correct.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170228005347/en/
Source: CONMED Corporation
CONMED Corporation
Luke A. Pomilio, 315-624-3202
Chief
Financial Officer